Previous close | 273.01 |
Open | 273.45 |
Bid | 269.36 x 100 |
Ask | 269.50 x 100 |
Day's range | 267.24 - 274.35 |
52-week range | 211.71 - 329.72 |
Volume | |
Avg. volume | 2,957,317 |
Market cap | 144.489B |
Beta (5Y monthly) | 0.60 |
PE ratio (TTM) | 21.55 |
EPS (TTM) | 12.50 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 9.00 (3.34%) |
Ex-dividend date | 16 May 2024 |
1y target est | 286.05 |
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.